Finlay Clinical Laboratory INC

Finlay Clinical Laboratory INC was paid $987K by Medicaid between Jan 2018 and Dec 2024, across 118 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 13% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Florida

Rank by total paid#42 of 225

Median peer was paid$74K

This provider vs. median13×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	113,717	$129K
2019	165,443	$145K
2020	176,779	$135K
2021	175,713	$255K
2022	134,604	$106K
2023	149,975	$176K
2024incomplete	103,331	$41K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	13%	20,190	6,223	$126K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	11%	17,398	12,328	$108K
80053	Comprehensive metabolic panel	9.7%	68,105	46,881	$95K
84443	Thyroid stimulating hormone (TSH)	8.8%	41,683	29,982	$87K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	8.5%	97,779	61,417	$84K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	8.4%	18,538	5,371	$83K
80061	Lipid panel	4.3%	47,356	34,631	$42K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	4.1%	2,082	1,899	$40K
83721		3.6%	47,108	34,484	$35K
83036	Hemoglobin; glycosylated (A1C)	2.4%	43,269	30,793	$24K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	2.2%	1,932	1,762	$22K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	2.1%	1,670	1,569	$21K

106 more codes

88142		1.9%	2,074	$19K
82565		1.7%	97,739	$17K
87070		1.7%	5,637	$16K
87086	Culture, bacterial; quantitative colony count, urine	1.5%	26,416	$15K
81000		1.3%	44,454	$13K
84153		1.3%	5,337	$13K
82607		1.2%	19,303	$12K
83970		<1%	4,285	$9K
80048	Basic metabolic panel (calcium, ionized)	<1%	29,477	$7K
84481		<1%	2,086	$7K
84439		<1%	5,901	$7K
82728		<1%	7,024	$5K
82746		<1%	8,615	$4K
87186		<1%	15,809	$4K
36415	Collection of venous blood by venipuncture	<1%	101,939	$4K
87077		<1%	3,045	$3K
80164		<1%	4,038	$3K
80177		<1%	1,627	$3K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	649	$3K
84436		<1%	14,247	$3K
84702		<1%	239	$2K
83550		<1%	8,704	$2K
84479		<1%	10,004	$2K
85610		<1%	9,099	$2K
87210		<1%	745	$2K
87088		<1%	13,230	$2K
83540		<1%	10,722	$2K
86703		<1%	680	$2K
83880		<1%	943	$2K
85730		<1%	4,837	$2K
84703		<1%	372	$2K
82270		<1%	3,917	$1K
86803		<1%	1,590	$1K
85651		<1%	9,938	$1K
86038		<1%	702	$1K
84550		<1%	15,453	$1K
86769		<1%	1,034	$1K
86140		<1%	4,952	$1K
87340		<1%	1,647	$1K
82140		<1%	2,854	$1K
84403		<1%	383	$1K
84480		<1%	2,457	$1K
83002		<1%	93	$1K
83001		<1%	95	$999.34
86592		<1%	1,585	$876.60
82043		<1%	7,869	$827.65
86430		<1%	1,916	$790.57
86709		<1%	1,234	$784.88
84134		<1%	3,184	$695.53
87324		<1%	521	$634.34
82652		<1%	10,434	$615.18
83090		<1%	1,065	$552.68
82570		<1%	4,471	$548.36
86376		<1%	71	$501.99
P9603	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled	<1%	36,121	$494.35
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	530	$480.12
87177		<1%	171	$439.47
84144		<1%	41	$418.08
86403		<1%	687	$417.90
84100		<1%	7,524	$405.69
86063		<1%	707	$355.38
86696		<1%	38	$344.77
80076		<1%	1,766	$337.16
82378		<1%	1,018	$323.65
82040		<1%	918	$319.99
80299		<1%	849	$304.98
83735		<1%	5,752	$283.80
83690		<1%	810	$257.94
86694		<1%	37	$257.50
84146		<1%	17	$237.00
86695		<1%	38	$232.99
85014		<1%	1,138	$215.37
88141		<1%	27	$211.68
82150		<1%	828	$205.35
87045		<1%	122	$152.39
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	2,740	$136.01
85044		<1%	704	$132.88
83615		<1%	1,407	$113.08
82947		<1%	27	$73.91
86200		<1%	90	$47.94
86677		<1%	58	$46.92
84154		<1%	356	$43.95
80162		<1%	417	$40.57
84402		<1%	18	$40.10
86334		<1%	107	$34.84
84075		<1%	278	$32.29
82550		<1%	349	$29.59
82465		<1%	49	$20.44
84155		<1%	471	$20.09
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	94	$16.10
84466		<1%	13	$10.94
80185		<1%	17	$8.85
87449		<1%	346	$8.38
85018		<1%	1,371	$6.90
82044		<1%	17	$1.64
86325		0%	26	$0.00
82310		0%	34	$0.00
84165		0%	182	$0.00
84166		0%	13	$0.00
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	0%	231	$0.00
86235		0%	24	$0.00
G0103	Prostate cancer screening; prostate specific antigen test (psa)	0%	2,971	$0.00
G2024	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source	0%	3,741	$0.00
86141		0%	90	$0.00
85379		0%	204	$0.00
82784		0%	126	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLEMES, MARTHA (BILLING MANAGER)